Monotherapy of experimental metabolic syndrome: II. Study of cardiovascular effects
Metabolic syndrome belongs to the most important risk factors of cardiovascular diseases. The aim of this study was to investigate changes in cardiovascular system induced by high cholesterol and high fat diet (HCHF) in HTG rats and their influence by a pyridoindole antioxidant – SMe1EC2 (S). The ef...
Saved in:
Published in | Interdisciplinary toxicology Vol. 10; no. 3; pp. 86 - 92 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Slovakia
De Gruyter Open
01.11.2017
De Gruyter Poland Slovak Toxicology Society SETOX |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Metabolic syndrome belongs to the most important risk factors of cardiovascular diseases. The aim of this study was to investigate changes in cardiovascular system induced by high cholesterol and high fat diet (HCHF) in HTG rats and their influence by a pyridoindole antioxidant – SMe1EC2 (S). The effects of S were compared with those of atorvastatin (A). Male HTG rats were fed HCHF (1% cholesterol + 7.5% lard) for 4 weeks. S and A were administered p.o., 50 mg/kg b.w. Following experimental groups were used: Wistar rats (W), hypertriglyceridemic rats (HTG), HTG rats fed HCHF (CHOL), HTG+S (S-HTG), CHOL+S (S-CHOL), and CHOL+A (A-CHOL). Values of blood pressure (BP) and selected ECG parameters were monitored in conscious animals, functions of the isolated heart and aorta were analyzed
. At the end of the experiment, systolic (sBP) and diastolic (dBP) blood pressure was increased in HTG and CHOL. S and A decreased BP in all treated groups. Accordingly with BP changes, the aortic endothelial function of CHOL was damaged. Both S and A administration ameliorated the endothelium-dependent relaxation to values of W. PQ and QTc intervals were prolonged in CHOL, while the treatment with S or A improved ECG findings. Prodysrhythmogenic threshold was decreased significantly in CHOL and both treatments returned it to the control values. In conclusion, HCHF increased BP, impaired endothelial relaxation of the aorta and potentiated susceptibility of myocardium to dysrhythmias. The effect of S on the changes induced by HCHF diet was more pronounced than that of A. |
---|---|
AbstractList | Metabolic syndrome belongs to the most important risk factors of cardiovascular diseases. The aim of this study was to investigate changes in cardiovascular system induced by high cholesterol and high fat diet (HCHF) in HTG rats and their influence by a pyridoindole antioxidant - SMe1EC2 (S). The effects of S were compared with those of atorvastatin (A). Male HTG rats were fed HCHF (1% cholesterol + 7.5% lard) for 4 weeks. S and A were administered p.o., 50 mg/kg b.w. Following experimental groups were used: Wistar rats (W), hypertriglyceridemic rats (HTG), HTG rats fed HCHF (CHOL), HTG+S (S-HTG), CHOL+S (S-CHOL), and CHOL+A (A-CHOL). Values of blood pressure (BP) and selected ECG parameters were monitored in conscious animals, functions of the isolated heart and aorta were analyzed
. At the end of the experiment, systolic (sBP) and diastolic (dBP) blood pressure was increased in HTG and CHOL. S and A decreased BP in all treated groups. Accordingly with BP changes, the aortic endothelial function of CHOL was damaged. Both S and A administration ameliorated the endothelium-dependent relaxation to values of W. PQ and QTc intervals were prolonged in CHOL, while the treatment with S or A improved ECG findings. Prodysrhythmogenic threshold was decreased significantly in CHOL and both treatments returned it to the control values. In conclusion, HCHF increased BP, impaired endothelial relaxation of the aorta and potentiated susceptibility of myocardium to dysrhythmias. The effect of S on the changes induced by HCHF diet was more pronounced than that of A. Metabolic syndrome belongs to the most important risk factors of cardiovascular diseases. The aim of this study was to investigate changes in cardiovascular system induced by high cholesterol and high fat diet (HCHF) in HTG rats and their influence by a pyridoindole antioxidant - SMe1EC2 (S). The effects of S were compared with those of atorvastatin (A). Male HTG rats were fed HCHF (1% cholesterol + 7.5% lard) for 4 weeks. S and A were administered p.o., 50 mg/kg b.w. Following experimental groups were used: Wistar rats (W), hypertriglyceridemic rats (HTG), HTG rats fed HCHF (CHOL), HTG+S (S-HTG), CHOL+S (S-CHOL), and CHOL+A (A-CHOL). Values of blood pressure (BP) and selected ECG parameters were monitored in conscious animals, functions of the isolated heart and aorta were analyzed [ex vivo]. At the end of the experiment, systolic (sBP) and diastolic (dBP) blood pressure was increased in HTG and CHOL. S and A decreased BP in all treated groups. Accordingly with BP changes, the aortic endothelial function of CHOL was damaged. Both S and A administration ameliorated the endothelium-dependent relaxation to values of W. PQ and QTc intervals were prolonged in CHOL, while the treatment with S or A improved ECG findings. Prodysrhythmogenic threshold was decreased significantly in CHOL and both treatments returned it to the control values. In conclusion, HCHF increased BP, impaired endothelial relaxation of the aorta and potentiated susceptibility of myocardium to dysrhythmias. The effect of S on the changes induced by HCHF diet was more pronounced than that of A. Abstract Metabolic syndrome belongs to the most important risk factors of cardiovascular diseases. The aim of this study was to investigate changes in cardiovascular system induced by high cholesterol and high fat diet (HCHF) in HTG rats and their influence by a pyridoindole antioxidant – SMe1EC2 (S). The effects of S were compared with those of atorvastatin (A). Male HTG rats were fed HCHF (1% cholesterol + 7.5% lard) for 4 weeks. S and A were administered p.o., 50 mg/kg b.w. Following experimental groups were used: Wistar rats (W), hypertriglyceridemic rats (HTG), HTG rats fed HCHF (CHOL), HTG+S (S-HTG), CHOL+S (S-CHOL), and CHOL+A (A-CHOL). Values of blood pressure (BP) and selected ECG parameters were monitored in conscious animals, functions of the isolated heart and aorta were analyzed ex vivo . At the end of the experiment, systolic (sBP) and diastolic (dBP) blood pressure was increased in HTG and CHOL. S and A decreased BP in all treated groups. Accordingly with BP changes, the aortic endothelial function of CHOL was damaged. Both S and A administration ameliorated the endothelium-dependent relaxation to values of W. PQ and QTc intervals were prolonged in CHOL, while the treatment with S or A improved ECG findings. Prodysrhythmogenic threshold was decreased significantly in CHOL and both treatments returned it to the control values. In conclusion, HCHF increased BP, impaired endothelial relaxation of the aorta and potentiated susceptibility of myocardium to dysrhythmias. The effect of S on the changes induced by HCHF diet was more pronounced than that of A. Metabolic syndrome belongs to the most important risk factors of cardiovascular diseases. The aim of this study was to investigate changes in cardiovascular system induced by high cholesterol and high fat diet (HCHF) in HTG rats and their influence by a pyridoindole antioxidant – SMe1EC2 (S). The effects of S were compared with those of atorvastatin (A). Male HTG rats were fed HCHF (1% cholesterol + 7.5% lard) for 4 weeks. S and A were administered p.o., 50 mg/kg b.w. Following experimental groups were used: Wistar rats (W), hypertriglyceridemic rats (HTG), HTG rats fed HCHF (CHOL), HTG+S (S-HTG), CHOL+S (S-CHOL), and CHOL+A (A-CHOL). Values of blood pressure (BP) and selected ECG parameters were monitored in conscious animals, functions of the isolated heart and aorta were analyzed ex vivo . At the end of the experiment, systolic (sBP) and diastolic (dBP) blood pressure was increased in HTG and CHOL. S and A decreased BP in all treated groups. Accordingly with BP changes, the aortic endothelial function of CHOL was damaged. Both S and A administration ameliorated the endothelium-dependent relaxation to values of W. PQ and QTc intervals were prolonged in CHOL, while the treatment with S or A improved ECG findings. Prodysrhythmogenic threshold was decreased significantly in CHOL and both treatments returned it to the control values. In conclusion, HCHF increased BP, impaired endothelial relaxation of the aorta and potentiated susceptibility of myocardium to dysrhythmias. The effect of S on the changes induced by HCHF diet was more pronounced than that of A. |
Author | Bauer, Viktor Stankovičová, Tatiana Brnoliaková, Zuzana Knezl, Vladimír Bezek, Štefan Sotníková, Ružena |
Author_xml | – sequence: 1 givenname: Vladimír surname: Knezl fullname: Knezl, Vladimír organization: Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská 9, 841 04 Bratislava, Slovakia – sequence: 2 givenname: Ružena surname: Sotníková fullname: Sotníková, Ružena organization: Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská 9, 841 04 Bratislava, Slovakia – sequence: 3 givenname: Zuzana surname: Brnoliaková fullname: Brnoliaková, Zuzana organization: Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská 9, 841 04 Bratislava, Slovakia – sequence: 4 givenname: Tatiana surname: Stankovičová fullname: Stankovičová, Tatiana organization: Department of Pharmacology and Toxicology, Comenius University in Bratislava, Faculty of Pharmacy, Odbojárov 10, 832 32 Bratislava 3, Slovakia – sequence: 5 givenname: Viktor surname: Bauer fullname: Bauer, Viktor organization: Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská 9, 841 04 Bratislava, Slovakia – sequence: 6 givenname: Štefan surname: Bezek fullname: Bezek, Štefan email: exfastbe@savba.sk organization: Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská 9, 841 04 Bratislava, Slovakia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30174531$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kc1P3DAQxS0EAgqcuVWReg6M17FjV6hShSisBOIAnC3HHkNQNl7shLL_PV52-eihc5mR_Js3T37fyGYfeiTkkMIR5ZQft_0QXsoJ0LoEoNUG2aWM1aXiQm2uZyE52yEHKT1CLka5rMQ22WF5p-KM7pKbq9CH4QGjmS-K4At8mWNsZ9gPpitmOJgmdK0t0qJ3MczwZzGdHhU3w-jeaGuia8OzSXbsTCzQe7RD2idb3nQJD9Z9j9z9Obs9vSgvr8-np78vS8ukEmVljZPOcuWkmMhKUWQ1ZtMCBDQUamXBS87lhIuGN7UF9HWdWZCofOU82yO_VrrzsZmhs9l0NJ2eZ_8mLnQwrf73pW8f9H141iKri0pmgR9rgRieRkyDfgxj7LNnPQFQAphQkKnjFWVjSCmi_7hAQS-D0G9B6GUQehlE3vj-1dgH__7tGThZAX9NN2B0eB_HRR4-7_9HmgKTgr0C5Tebcw |
CitedBy_id | crossref_primary_10_1093_ehjcvp_pvac053 crossref_primary_10_33549_physiolres_934670 crossref_primary_10_2174_1573399817666210414103730 crossref_primary_10_2478_intox_2019_0024 crossref_primary_10_33549_physiolres_935021 |
Cites_doi | 10.1152/ajpheart.00535.2012 10.1016/j.pharep.2016.04.022 10.1113/expphysiol.2013.074948 10.1016/j.jelectrocard.2012.02.004 10.1186/1476-511X-13-168 10.1006/jmcc.1996.0359 10.1097/MJT.0b013e31823735aa 10.1161/01.CIR.70.1.123 10.1586/14779072.2014.952283 10.1007/s10571-006-9037-9 10.1016/S1734-1140(11)70612-0 10.1161/01.RES.67.5.1115 10.1161/01.RES.68.5.1378 10.1161/hc3201.094151 10.1186/s12906-017-1603-9 10.1007/s00228-016-2043-z 10.4149/BLL_2017_103 10.1161/01.CIR.80.6.1675 |
ContentType | Journal Article |
Copyright | Copyright De Gruyter Open Sp. z o.o. 2017 Copyright © 2017 SETOX & Institute of Experimental Pharmacology and Toxicology, SASc. 2017 |
Copyright_xml | – notice: Copyright De Gruyter Open Sp. z o.o. 2017 – notice: Copyright © 2017 SETOX & Institute of Experimental Pharmacology and Toxicology, SASc. 2017 |
DBID | NPM AAYXX CITATION 3V. 7RV 7U7 7X7 7XB 8AO 8C1 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA ATCPS AZQEC BBNVY BENPR BHPHI BYOGL C1K CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. KB0 LK8 M0S M7P NAPCQ PATMY PIMPY PQEST PQQKQ PQUKI PRINS PYCSY 5PM |
DOI | 10.1515/intox-2017-0014 |
DatabaseName | PubMed CrossRef ProQuest Central (Corporate) ProQuest Nursing and Allied Health Journals Toxicology Abstracts Health & Medical Complete (ProQuest Database) ProQuest Central (purchase pre-March 2016) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection AUTh Library subscriptions: ProQuest Central ProQuest Natural Science Collection East Europe, Central Europe Database Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection (Proquest) (PQ_SDU_P3) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences Health & Medical Collection (Alumni Edition) Biological Science Database Nursing & Allied Health Premium Environmental Science Database Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Environmental Science Collection PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef Publicly Available Content Database ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Agricultural & Environmental Science Collection Biological Science Collection ProQuest Public Health ProQuest Biological Science Collection Toxicology Abstracts ProQuest One Academic Eastern Edition East Europe, Central Europe Database ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Environmental Science Collection Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | PubMed Publicly Available Content Database CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BYOGL name: East Europe, Central Europe Database url: https://proxy.k.utb.cz/login?url=https://search.proquest.com/eastcentraleurope sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1337-9569 |
EndPage | 92 |
ExternalDocumentID | 10_1515_intox_2017_0014 30174531 10_1515_intox_2017_001410386 |
Genre | Journal Article |
GroupedDBID | --- 0R~ 3V. 4.4 53G 5VS 73H 7RV 7X7 7XC 8AO 8C1 8FE 8FH 8FI 8FJ 9WM AAKDD AAPBV ABFKT ABUWG ACGFS ACPRK ADBBV ADBLJ AFKRA AFRAH AHGSO AHMBA AIKXB ALMA_UNASSIGNED_HOLDINGS AOIJS ATCPS BAWUL BBAFP BBNVY BCNDV BENPR BHPHI BKEYQ BPHCQ BVXVI BYOGL DIK E0C E3Z EBS EJD EX3 F5P FYUFA GROUPED_DOAJ HCIFZ HYE HZ~ KQ8 LK8 M48 M7P M~E NAPCQ O5R O5S O9- OK1 PATMY PIMPY PQEST PQQKQ PQUKI PRINS PROAC PYCSY QD8 RNS RPM SA. UKHRP WOW 9-L ADRAZ ADUQZ AGGNV ALIPV ASPBG AVWKF AZFZN CCPQU FEDTE HMCUK HVGLF IPNFZ MET NPM PGMZT RIG SLJYH ~Z8 AAYXX CITATION 7U7 7XB 8FK AZQEC C1K DWQXO GNUQQ K9. 5PM |
ID | FETCH-LOGICAL-c3896-4cad8dc59d8628491e37e3376060b1079c0f8558256b5b7c0ef77d8608e9f4df3 |
IEDL.DBID | RPM |
ISSN | 1337-6853 1337-9569 |
IngestDate | Tue Sep 17 21:28:58 EDT 2024 Thu Oct 10 18:04:52 EDT 2024 Fri Aug 23 02:37:37 EDT 2024 Wed Oct 16 00:59:05 EDT 2024 Fri Nov 25 00:40:18 EST 2022 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | metabolic syndrome high-fat and high-cholesterol diet atorvastatin SMe1EC2 cardiovascular effects |
Language | English |
License | This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License. (CC BY-NC-ND 4.0) |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3896-4cad8dc59d8628491e37e3376060b1079c0f8558256b5b7c0ef77d8608e9f4df3 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107648/ |
PMID | 30174531 |
PQID | 2009603690 |
PQPubID | 2026529 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6107648 proquest_journals_2009603690 crossref_primary_10_1515_intox_2017_0014 pubmed_primary_30174531 walterdegruyter_journals_10_1515_intox_2017_001410386 |
PublicationCentury | 2000 |
PublicationDate | 2017-11-1 |
PublicationDateYYYYMMDD | 2017-11-01 |
PublicationDate_xml | – month: 11 year: 2017 text: 2017-11-1 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Slovakia |
PublicationPlace_xml | – name: Slovakia – name: Bratislava |
PublicationTitle | Interdisciplinary toxicology |
PublicationTitleAlternate | Interdiscip Toxicol |
PublicationYear | 2017 |
Publisher | De Gruyter Open De Gruyter Poland Slovak Toxicology Society SETOX |
Publisher_xml | – name: De Gruyter Open – name: De Gruyter Poland – name: Slovak Toxicology Society SETOX |
References | 2021040803524870340_j_intox-2017-0014_ref_020_w2aab3b7b1b1b6b1ab1ac20Aa 2021040803524870340_j_intox-2017-0014_ref_028_w2aab3b7b1b1b6b1ab1ac28Aa 2021040803524870340_j_intox-2017-0014_ref_033_w2aab3b7b1b1b6b1ab1ac33Aa 2021040803524870340_j_intox-2017-0014_ref_041_w2aab3b7b1b1b6b1ab1ac41Aa 2021040803524870340_j_intox-2017-0014_ref_015_w2aab3b7b1b1b6b1ab1ac15Aa 2021040803524870340_j_intox-2017-0014_ref_001_w2aab3b7b1b1b6b1ab1ab1Aa 2021040803524870340_j_intox-2017-0014_ref_046_w2aab3b7b1b1b6b1ab1ac46Aa 2021040803524870340_j_intox-2017-0014_ref_012_w2aab3b7b1b1b6b1ab1ac12Aa 2021040803524870340_j_intox-2017-0014_ref_038_w2aab3b7b1b1b6b1ab1ac38Aa 2021040803524870340_j_intox-2017-0014_ref_043_w2aab3b7b1b1b6b1ab1ac43Aa 2021040803524870340_j_intox-2017-0014_ref_031_w2aab3b7b1b1b6b1ab1ac31Aa 2021040803524870340_j_intox-2017-0014_ref_025_w2aab3b7b1b1b6b1ab1ac25Aa 2021040803524870340_j_intox-2017-0014_ref_022_w2aab3b7b1b1b6b1ab1ac22Aa 2021040803524870340_j_intox-2017-0014_ref_035_w2aab3b7b1b1b6b1ab1ac35Aa 2021040803524870340_j_intox-2017-0014_ref_048_w2aab3b7b1b1b6b1ab1ac48Aa 2021040803524870340_j_intox-2017-0014_ref_017_w2aab3b7b1b1b6b1ab1ac17Aa 2021040803524870340_j_intox-2017-0014_ref_005_w2aab3b7b1b1b6b1ab1ab5Aa 2021040803524870340_j_intox-2017-0014_ref_032_w2aab3b7b1b1b6b1ab1ac32Aa 2021040803524870340_j_intox-2017-0014_ref_014_w2aab3b7b1b1b6b1ab1ac14Aa 2021040803524870340_j_intox-2017-0014_ref_027_w2aab3b7b1b1b6b1ab1ac27Aa 2021040803524870340_j_intox-2017-0014_ref_042_w2aab3b7b1b1b6b1ab1ac42Aa 2021040803524870340_j_intox-2017-0014_ref_045_w2aab3b7b1b1b6b1ab1ac45Aa 2021040803524870340_j_intox-2017-0014_ref_003_w2aab3b7b1b1b6b1ab1ab3Aa 2021040803524870340_j_intox-2017-0014_ref_011_w2aab3b7b1b1b6b1ab1ac11Aa 2021040803524870340_j_intox-2017-0014_ref_024_w2aab3b7b1b1b6b1ab1ac24Aa 2021040803524870340_j_intox-2017-0014_ref_037_w2aab3b7b1b1b6b1ab1ac37Aa 2021040803524870340_j_intox-2017-0014_ref_009_w2aab3b7b1b1b6b1ab1ab9Aa 2021040803524870340_j_intox-2017-0014_ref_029_w2aab3b7b1b1b6b1ab1ac29Aa 2021040803524870340_j_intox-2017-0014_ref_006_w2aab3b7b1b1b6b1ab1ab6Aa 2021040803524870340_j_intox-2017-0014_ref_021_w2aab3b7b1b1b6b1ab1ac21Aa 2021040803524870340_j_intox-2017-0014_ref_034_w2aab3b7b1b1b6b1ab1ac34Aa 2021040803524870340_j_intox-2017-0014_ref_047_w2aab3b7b1b1b6b1ab1ac47Aa 2021040803524870340_j_intox-2017-0014_ref_007_w2aab3b7b1b1b6b1ab1ab7Aa 2021040803524870340_j_intox-2017-0014_ref_016_w2aab3b7b1b1b6b1ab1ac16Aa 2021040803524870340_j_intox-2017-0014_ref_040_w2aab3b7b1b1b6b1ab1ac40Aa 2021040803524870340_j_intox-2017-0014_ref_019_w2aab3b7b1b1b6b1ab1ac19Aa 2021040803524870340_j_intox-2017-0014_ref_008_w2aab3b7b1b1b6b1ab1ab8Aa 2021040803524870340_j_intox-2017-0014_ref_004_w2aab3b7b1b1b6b1ab1ab4Aa 2021040803524870340_j_intox-2017-0014_ref_039_w2aab3b7b1b1b6b1ab1ac39Aa 2021040803524870340_j_intox-2017-0014_ref_044_w2aab3b7b1b1b6b1ab1ac44Aa 2021040803524870340_j_intox-2017-0014_ref_013_w2aab3b7b1b1b6b1ab1ac13Aa 2021040803524870340_j_intox-2017-0014_ref_018_w2aab3b7b1b1b6b1ab1ac18Aa 2021040803524870340_j_intox-2017-0014_ref_026_w2aab3b7b1b1b6b1ab1ac26Aa 2021040803524870340_j_intox-2017-0014_ref_030_w2aab3b7b1b1b6b1ab1ac30Aa 2021040803524870340_j_intox-2017-0014_ref_010_w2aab3b7b1b1b6b1ab1ac10Aa 2021040803524870340_j_intox-2017-0014_ref_049_w2aab3b7b1b1b6b1ab1ac49Aa 2021040803524870340_j_intox-2017-0014_ref_002_w2aab3b7b1b1b6b1ab1ab2Aa 2021040803524870340_j_intox-2017-0014_ref_023_w2aab3b7b1b1b6b1ab1ac23Aa 2021040803524870340_j_intox-2017-0014_ref_036_w2aab3b7b1b1b6b1ab1ac36Aa |
References_xml | – ident: 2021040803524870340_j_intox-2017-0014_ref_012_w2aab3b7b1b1b6b1ab1ac12Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_015_w2aab3b7b1b1b6b1ab1ac15Aa doi: 10.1152/ajpheart.00535.2012 – ident: 2021040803524870340_j_intox-2017-0014_ref_027_w2aab3b7b1b1b6b1ab1ac27Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_031_w2aab3b7b1b1b6b1ab1ac31Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_046_w2aab3b7b1b1b6b1ab1ac46Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_034_w2aab3b7b1b1b6b1ab1ac34Aa doi: 10.1016/j.pharep.2016.04.022 – ident: 2021040803524870340_j_intox-2017-0014_ref_044_w2aab3b7b1b1b6b1ab1ac44Aa doi: 10.1113/expphysiol.2013.074948 – ident: 2021040803524870340_j_intox-2017-0014_ref_016_w2aab3b7b1b1b6b1ab1ac16Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_023_w2aab3b7b1b1b6b1ab1ac23Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_042_w2aab3b7b1b1b6b1ab1ac42Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_039_w2aab3b7b1b1b6b1ab1ac39Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_004_w2aab3b7b1b1b6b1ab1ab4Aa doi: 10.1016/j.jelectrocard.2012.02.004 – ident: 2021040803524870340_j_intox-2017-0014_ref_011_w2aab3b7b1b1b6b1ab1ac11Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_049_w2aab3b7b1b1b6b1ab1ac49Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_026_w2aab3b7b1b1b6b1ab1ac26Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_048_w2aab3b7b1b1b6b1ab1ac48Aa doi: 10.1186/1476-511X-13-168 – ident: 2021040803524870340_j_intox-2017-0014_ref_035_w2aab3b7b1b1b6b1ab1ac35Aa doi: 10.1006/jmcc.1996.0359 – ident: 2021040803524870340_j_intox-2017-0014_ref_022_w2aab3b7b1b1b6b1ab1ac22Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_045_w2aab3b7b1b1b6b1ab1ac45Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_008_w2aab3b7b1b1b6b1ab1ab8Aa doi: 10.1097/MJT.0b013e31823735aa – ident: 2021040803524870340_j_intox-2017-0014_ref_019_w2aab3b7b1b1b6b1ab1ac19Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_033_w2aab3b7b1b1b6b1ab1ac33Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_010_w2aab3b7b1b1b6b1ab1ac10Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_041_w2aab3b7b1b1b6b1ab1ac41Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_003_w2aab3b7b1b1b6b1ab1ab3Aa doi: 10.1161/01.CIR.70.1.123 – ident: 2021040803524870340_j_intox-2017-0014_ref_005_w2aab3b7b1b1b6b1ab1ab5Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_029_w2aab3b7b1b1b6b1ab1ac29Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_030_w2aab3b7b1b1b6b1ab1ac30Aa doi: 10.1586/14779072.2014.952283 – ident: 2021040803524870340_j_intox-2017-0014_ref_038_w2aab3b7b1b1b6b1ab1ac38Aa doi: 10.1007/s10571-006-9037-9 – ident: 2021040803524870340_j_intox-2017-0014_ref_007_w2aab3b7b1b1b6b1ab1ab7Aa doi: 10.1016/S1734-1140(11)70612-0 – ident: 2021040803524870340_j_intox-2017-0014_ref_037_w2aab3b7b1b1b6b1ab1ac37Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_025_w2aab3b7b1b1b6b1ab1ac25Aa doi: 10.1161/01.RES.67.5.1115 – ident: 2021040803524870340_j_intox-2017-0014_ref_020_w2aab3b7b1b1b6b1ab1ac20Aa doi: 10.1161/01.RES.68.5.1378 – ident: 2021040803524870340_j_intox-2017-0014_ref_021_w2aab3b7b1b1b6b1ab1ac21Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_001_w2aab3b7b1b1b6b1ab1ab1Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_014_w2aab3b7b1b1b6b1ab1ac14Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_017_w2aab3b7b1b1b6b1ab1ac17Aa doi: 10.1161/hc3201.094151 – ident: 2021040803524870340_j_intox-2017-0014_ref_006_w2aab3b7b1b1b6b1ab1ab6Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_047_w2aab3b7b1b1b6b1ab1ac47Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_040_w2aab3b7b1b1b6b1ab1ac40Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_032_w2aab3b7b1b1b6b1ab1ac32Aa doi: 10.1186/s12906-017-1603-9 – ident: 2021040803524870340_j_intox-2017-0014_ref_002_w2aab3b7b1b1b6b1ab1ab2Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_009_w2aab3b7b1b1b6b1ab1ab9Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_043_w2aab3b7b1b1b6b1ab1ac43Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_028_w2aab3b7b1b1b6b1ab1ac28Aa doi: 10.1007/s00228-016-2043-z – ident: 2021040803524870340_j_intox-2017-0014_ref_013_w2aab3b7b1b1b6b1ab1ac13Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_018_w2aab3b7b1b1b6b1ab1ac18Aa doi: 10.4149/BLL_2017_103 – ident: 2021040803524870340_j_intox-2017-0014_ref_036_w2aab3b7b1b1b6b1ab1ac36Aa – ident: 2021040803524870340_j_intox-2017-0014_ref_024_w2aab3b7b1b1b6b1ab1ac24Aa doi: 10.1161/01.CIR.80.6.1675 |
SSID | ssj0000315846 |
Score | 2.1518304 |
Snippet | Metabolic syndrome belongs to the most important risk factors of cardiovascular diseases. The aim of this study was to investigate changes in cardiovascular... Abstract Metabolic syndrome belongs to the most important risk factors of cardiovascular diseases. The aim of this study was to investigate changes in... |
SourceID | pubmedcentral proquest crossref pubmed walterdegruyter |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 86 |
SubjectTerms | Antioxidants Aorta Atorvastatin Blood pressure Cardiovascular diseases cardiovascular effects Cardiovascular system Cholesterol Coronary vessels Diet Echocardiography EKG Endothelium Health risks Heart diseases High cholesterol diet High fat diet high-fat and high-cholesterol diet Metabolic syndrome Myocardium Original Rats Risk analysis Risk factors Rodents SMe1EC2 |
SummonAdditionalLinks | – databaseName: AUTh Library subscriptions: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV07T8MwELagLEio4k15yQMDS8BNnNhhQYBAgESFgEpsUevY0IGk0FTQf8-d47SUCuackuh8vvd3R8iBYUyDV6u8gGvmca5AD8ZceFr4vlAy9pWPaOS7VnTd5rfP4bNLuA1cW2WlE62iTnOFOfJj3zrbAQRzp_13D7dGYXXVrdCYJwt-k2OZduH8snX_MM6y4A4DWUKMAsTDgXFy833Ajh_3siL_AjkBRY2hwrRpmvE3Z9sm65-2pJ3ql4_hqKhKqNYyXS2TunMp6VkpAytkTmerZKnMx9ESZrRGHuHyOrDViOaG_pzsT990AbKA5NUAgxN6c3NEscnQUquprlXqmkDWSfvq8uni2nMLFTwFfknkcdVJZarCOIU4RvK4qQOhA2yLiVgX4sBYMSPDEILGqBt2hWLaCAG0TOrY8NQEG6SW5ZneIlR3moERCKRHMG4oO0wapplJU1AIQvEGOax4mfTLuRkJxhvA9sSyPUG2Y0cdkO5WvE7cBRokk-NukM2S7eP3gE4SHHRHg4ipAxkT4Mjs6SdZ79WOzgZnUURcNkj46-gmX_7jL3GQfLT9_6_ukEUrTBaquEtqxcdQ74HPUnT3nWB-A85s64Q priority: 102 providerName: ProQuest |
Title | Monotherapy of experimental metabolic syndrome: II. Study of cardiovascular effects |
URI | http://www.degruyter.com/doi/10.1515/intox-2017-0014 https://www.ncbi.nlm.nih.gov/pubmed/30174531 https://www.proquest.com/docview/2009603690 https://pubmed.ncbi.nlm.nih.gov/PMC6107648 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB58gAgivl0fSw4evHQ33SRN6k2XFRUU8QF7K9s00QW3K1pR_72TtFVX8eKlUDo0ZeZLZqb5ZgKwZyk1GNXqgHFDA841roMxl4GRnY7UKu7ojqtGPr-ITm75WV_0p0DUtTCetK_TYSt_GLXy4b3nVj6OdLvmibUvz7vo8mXEVXsapiVj31J0v_yy0DlVn2i5Ejj0R1VLH3Td7WFejN8QGrg2u-xgHuYQ4ZILFk46pl_R5m_S5OKr39DOzN3Ty3tRb6B6v3S8BItVQEkOyw9fhimTr8BC-TeOlEVGq3CNU7cqtXonY0u-9_UnI1MgEpx43b7ggJyetoijGHppPcFZJRUFZA1uj3s33ZOgOk4h0BiVRAHXg0xlWsQZZjGKx6Fh0jBHioloihqNNbVKCEwZo1SkUlNjpURZqkxseWbZOszk49xsAjGDkFnpyuhdKa5QA6osNdRmGS4HUvMG7Ne6TB7LrhmJyzbQAom3QOIs4Ph0KLpT6zqpps-zOxsTMyuGmXsDNkq1f76ntlcD5IRBPgVcw-zJJ4gj3zi7wk0DxA_TfY38x1e6NvLR1r9H3IZ5Dzlfw7gDM8XTi9nFYKZImwjhvsSr6oZNmD3qXVxe4V2Pdpse1h9kdvdG |
link.rule.ids | 230,315,733,786,790,891,12083,12250,21416,27955,27956,31752,33299,33777,43343,43612,43838,53825,53827,67036,67513,68820,69297 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLZgHEBCiDfjmQMHLoWsTZuUC0IItPG6ABK3aksT4EAHrAj499hpOhgIzrWayHH8ij8bYNtybtCr1UEkDA-E0KgHUyEDI8NQapWGOiQ08sVl0r4Rp7fxrU-4DXxZZa0TnaLO-5py5Huhc7YjDOYOnp4DmhpFr6t-hMY4TIgIbTUhxY9awxwLTTBQFcAoIjQcmibf3Qet-N5DUfbfUUpQTVOgMGqYfnmbv4smZ97cg3Zu7l5eP8r6AdXZpZNZmPEOJTusJGAOxkwxD9NVNo5VIKMFuMKr66FWH6xv2fe-_uzRlCgJRF63L9hnnc4uoxJDR61HalaZLwFZhJuT4-ujduDHKQQavZIkELqbq1zHaY5RjBJpy0TSRFQUk_AeRoGp5lbFMYaMSS_uSc2NlRJpuTKpFbmNlqBR9AuzAsx0W5GVBKMnKG6sulxZbrjNc1QHUosm7NS8zJ6qrhkZRRvI9syxPSO2Uz0dkq7XvM789RlkX4fdhOWK7cP_oEaSAjVHE-TIgQwJqGH26Jfi4d41zkZXUSZCNSH-cXRfK_-xS2ojn6z-v9UtmGxfX5xn553LszWYcoLlQIvr0ChfXs0Gei9lb9OJ6Ce6xOzW |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB1BkRASYl_K6gMHLkncxIkTbgioKJuQAAlxiRrHhgqaVpCK5esZOwm0IC6cM4ptvfEsyZsZgB1FqcSoVlgek9RiTKAdjBi3JHddLsLIFa6uRj6_CI5v2Mmtfzs06suQ9kXSsbOnrp11Hgy3st8VTsUTcy7PD9Dl84CFTj9VzjhM4J11-VCiboyw19Cu1aRbuhAOvVLZ2AcduNPJ8t4bKghaaJ0jTMEk6jlnvtcYdU-_Ys7f1MmZV_NbO5X3z4P3vPqNarxTcxbuqnMVpJRHe5Antvj40fLxXwefg5kyZiX7hcg8jMlsAaaLD36kqGNahCu0DmU11zvpKTI8OoB0ZY7KpsWrDgl7pNWyiWYxGmkxQoslJctkCW6aR9cHx1Y5scESGPgEFhPtNEyFH6WYKIUsakiPS0_zbgKa4N4jQVXo-5iVBomfcEGl4hxlaSgjxVLlLUMt62VyFYhsNzzFdaW-rvb1wzYNFZVUpSlaHC5YHXYroOJ-0Zgj1gkNwhsbeGMNr6bsoehGBWRc3tAXPX4TkzcviGgdVgpMv95TKUMd-AjaXwK6J_foE0TM9OYuEaqD_0Mvvlf-Y5e6U32w9u8Vt2Hy8rAZn7UuTtdhyqi2qZjcgFr-PJCbGDrlyZa5JJ9jnhek |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Monotherapy+of+experimental+metabolic+syndrome%3A+II.+Study+of+cardiovascular+effects&rft.jtitle=Interdisciplinary+toxicology&rft.au=Knezl%2C+Vladim%C3%ADr&rft.au=Sotn%C3%ADkov%C3%A1%2C+Ru%C5%BEena&rft.au=Brnoliakov%C3%A1%2C+Zuzana&rft.au=Stankovi%C4%8Dov%C3%A1%2C+Tatiana&rft.date=2017-11-01&rft.issn=1337-6853&rft.volume=10&rft.issue=3&rft.spage=86&rft_id=info:doi/10.1515%2Fintox-2017-0014&rft_id=info%3Apmid%2F30174531&rft.externalDocID=30174531 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1337-6853&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1337-6853&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1337-6853&client=summon |